MiR-133b, a Particular Member of MyomiRs, Coming into Playing Its Unique Pathological Role in Human Cancer

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Apr 20

PMID 28422730

Citations 22

Authors

Daojiang Li

Lu Xia

Miao Chen

Changwei Lin

Hao Wu

Yi Zhang

Songqing Pan

Xiaorong Li

Affiliations

Soon will be listed here.

Abstract

MicroRNAs, a family of single-stranded and non-coding RNAs, play a crucial role in regulating gene expression at posttranscriptional level, by which it can mediate various types of physiological and pathological process in normal developmental progress and human disease, including cancer. The microRNA-133b originally defined as canonical muscle-specific microRNAs considering their function to the development and health of mammalian skeletal and cardiac muscles, but new findings coming from our group and others revealed that miR-133b have frequently abnormal expression in various kinds of human cancer and its complex complicated regulatory networks affects the tumorigenicity and development of malignant tumors. Very few existing reviews on miR-133b, until now, are principally about its role in homologous cluster (miR-1, -133 and -206s), however, most of constantly emerging new researches now are focused mainly on one of them, so In this article, to highlight the unique pathological role of miR-133b playing in tumor, we conduct a review to summarize the current understanding about one of the muscle-specific microRNAs, namely miR-133b, acting in human cancer. The review focused on the following four aspects: the overview of miR-133b, the target genes of miR-133b involved in human cancer, the expression of miR-133b and regulatory mechanisms leading to abnormal expression of miR-133b.

Citing Articles

Importance of STAT3 signaling in preeclampsia (Review).

Marzioni D, Piani F, Di Simone N, Giannubilo S, Ciavattini A, Tossetta G Int J Mol Med. 2025; 55(4).

PMID: 39918020 PMC: 11878484. DOI: 10.3892/ijmm.2025.5499.

Exercise-induced extracellular vesicles in reprogramming energy metabolism in cancer.

Puurand M, Llorente A, Line A, Kaambre T Front Oncol. 2025; 14():1480074.

PMID: 39834935 PMC: 11743358. DOI: 10.3389/fonc.2024.1480074.

Exosomes and microRNAs as mediators of the exercise.

Li H, Liu G, Wang B, Momeni M Eur J Med Res. 2025; 30(1):38.

PMID: 39828711 PMC: 11742998. DOI: 10.1186/s40001-025-02273-4.

From sweat to hope: The role of exercise-induced extracellular vesicles in cancer prevention and treatment.

Llorente A, Brokane A, Mlynska A, Puurand M, Sagini K, Folkmane S J Extracell Vesicles. 2024; 13(8):e12500.

PMID: 39183543 PMC: 11345496. DOI: 10.1002/jev2.12500.

Topology and Dynamics of Transcriptome (Dys)Regulation.

Planat M, Chester D Int J Mol Sci. 2024; 25(9).

PMID: 38732192 PMC: 11084388. DOI: 10.3390/ijms25094971.

References

Azizian A, Epping I, Kramer F, Jo P, Bernhardt M, Kitz J . Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer. Int J Mol Sci. 2016; 17(4):568. PMC: 4849024. DOI: 10.3390/ijms17040568. View

Chen M, Zhang J, Manley J . Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010; 70(22):8977-80. PMC: 2982937. DOI: 10.1158/0008-5472.CAN-10-2513. View

Ellermeier C, Vang S, Cleveland K, Durand W, Resnick M, Brodsky A . Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors. Anticancer Res. 2014; 34(8):3957-67. View

Li X, Wan X, Chen H, Yang S, Liu Y, Mo W . Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer. Clin Cancer Res. 2014; 20(9):2312-25. DOI: 10.1158/1078-0432.CCR-13-1588. View

Kara M, Yumrutas O, Ozcan O, Celik O, Bozgeyik E, Bozgeyik I . Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015; 567(1):81-6. DOI: 10.1016/j.gene.2015.04.065. View

de Cubas A, Leandro-Garcia L, Schiavi F, Mancikova V, Comino-Mendez I, Inglada-Perez L . Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways. Endocr Relat Cancer. 2013; 20(4):477-93. DOI: 10.1530/ERC-12-0183. View

Wu J, Yang T, Li X, Yang Q, Liu R, Huang J . Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Toxicol Appl Pharmacol. 2013; 267(3):238-46. DOI: 10.1016/j.taap.2013.01.002. View

Li J, Liu S, Zhou H, Qu L, Yang J . starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2013; 42(Database issue):D92-7. PMC: 3964941. DOI: 10.1093/nar/gkt1248. View

Qin W, Dong P, Ma C, Mitchelson K, Deng T, Zhang L . MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene. 2011; 31(36):4067-75. DOI: 10.1038/onc.2011.561. View

10.

Stumpfova Z, Hezova R, Meli A, Slaby O, Michalek J . MicroRNA profiling of activated and tolerogenic human dendritic cells. Mediators Inflamm. 2014; 2014:259689. PMC: 3995309. DOI: 10.1155/2014/259689. View

11.

Han C, Yu Z, Duan Z, Kan Q . Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014; 2014:428371. PMC: 4052501. DOI: 10.1155/2014/428371. View

12.

Chan M, Liaw C, Ji S, Tan H, Wong C, Thike A . Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res. 2013; 19(16):4477-87. DOI: 10.1158/1078-0432.CCR-12-3401. View

13.

Xiang K, Li X . MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells. Asian Pac J Cancer Prev. 2014; 15(8):3767-72. DOI: 10.7314/apjcp.2014.15.8.3767. View

14.

El-Halawany M, Ismail H, Zeeneldin A, Elfiky A, Tantawy M, Kobaisi M . Investigating the pretreatment miRNA expression patterns of advanced hepatocellular carcinoma patients in association with response to TACE treatment. Biomed Res Int. 2015; 2015:649750. PMC: 4355598. DOI: 10.1155/2015/649750. View

15.

Quinn J, Chang H . Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015; 17(1):47-62. DOI: 10.1038/nrg.2015.10. View

16.

Zhang C, Yao C, Li H, Wang G, He X . Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol. 2014; 7(7):4194-203. PMC: 4129034. View

17.

Dyrskjot L, Ostenfeld M, Bramsen J, Silahtaroglu A, Lamy P, Ramanathan R . Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009; 69(11):4851-60. DOI: 10.1158/0008-5472.CAN-08-4043. View

18.

Bhattacharjya S, Roy K, Ganguly A, Sarkar S, Panda C, Bhattacharyya D . Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death. Mol Cancer. 2015; 14:42. PMC: 4335456. DOI: 10.1186/s12943-015-0299-z. View

19.

Weiss M, Brandenburg L, Burchardt M, Stope M . MicroRNA-1 properties in cancer regulatory networks and tumor biology. Crit Rev Oncol Hematol. 2016; 104:71-7. DOI: 10.1016/j.critrevonc.2016.05.014. View

20.

Chen X, Wang K, Xu Z, Li S, Liu Q, Fu D . MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer Cell Int. 2014; 14:70. PMC: 4238049. DOI: 10.1186/s12935-014-0070-3. View